Erl 080A Erl+Tab


Indications and Reactions:

Role Indications Reactions
Primary
Renal Transplant 65.6%
Immunosuppression 14.2%
Lung Transplant 10.6%
Hypertension 1.4%
Systemic Lupus Erythematosus 1.4%
Lupus Nephritis 0.8%
Prophylaxis 0.8%
Cholecystitis 0.6%
Depression 0.6%
Diabetes Mellitus 0.6%
Pyelonephritis Chronic 0.6%
Renal Failure Acute 0.6%
Deep Vein Thrombosis 0.3%
Dementia Alzheimer's Type 0.3%
Diagnostic Procedure 0.3%
Diarrhoea 0.3%
Hypercalcaemia 0.3%
Hyperlipidaemia 0.3%
Hypothyroidism 0.3%
Impaired Gastric Emptying 0.3%
Vomiting 21.2%
Pyrexia 19.2%
Weight Decreased 6.1%
Hyperthermia 5.1%
Renal Failure Acute 5.1%
Urinary Tract Infection 5.1%
Thoracic Cavity Drainage 4.0%
Tracheobronchitis 4.0%
Dyspnoea 3.0%
Renal Failure 3.0%
Rhinorrhoea 3.0%
Transplant Rejection 3.0%
Viral Infection 3.0%
White Blood Cell Count Decreased 3.0%
Bronchiectasis 2.0%
Enteritis 2.0%
Leukopenia 2.0%
Localised Intraabdominal Fluid Collection 2.0%
Lung Transplant Rejection 2.0%
Nephropathy Toxic 2.0%
Secondary
Renal Transplant 70.4%
Immunosuppression 8.6%
Lung Transplant 7.3%
Hypertension 2.7%
Systemic Lupus Erythematosus 2.7%
Prophylaxis 2.0%
Diabetes Mellitus 1.3%
Pain 1.0%
Cholecystitis 0.7%
Impaired Gastric Emptying 0.7%
Laxative Supportive Care 0.7%
Lupus Nephritis 0.7%
Diagnostic Procedure 0.3%
Diarrhoea 0.3%
Prophylaxis Against Transplant Rejection 0.3%
Steroid Therapy 0.3%
Vomiting 21.5%
Pyrexia 9.3%
Renal Failure Acute 6.5%
Renal Tubular Disorder 6.5%
Urinary Tract Infection 4.7%
Varicella 4.7%
West Nile Viral Infection 4.7%
Leukopenia 3.7%
Renal Impairment 3.7%
Thoracic Cavity Drainage 3.7%
Tracheobronchitis 3.7%
Urine Output Decreased 3.7%
Viral Infection 3.7%
Weight Decreased 3.7%
White Blood Cell Count Decreased 3.7%
White Blood Cell Count Increased 3.7%
Wound Infection Staphylococcal 2.8%
Pancytopenia 1.9%
Pleural Effusion 1.9%
Renal Tubular Atrophy 1.9%

Drug Data